Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Basiliximab in High-Risk Keratoplasty
NCT00409656Phase 2Completed
- Sponsor
- University Hospital Freiburg
- Start
- Dec 2003
- Modality
- Monoclonal Antibodies
01
Overview
A Phase 2 trial of basiliximab in corneal transplantation, sponsored by University Hospital Freiburg. Started Dec 2003; status: completed.
02
Drugs
basiliximab
03
Conditions
corneal transplantation
Beyond the preview
Go deeper on NCT00409656.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00409656.